Publications by authors named "Sarah B Schuchard"
Background: Hydroxyurea (HU) reduces complications and improves quality and duration of life in sickle cell disease. Evidence supports the use of HU starting after nine months of age.
Procedures: We performed a retrospective study of patients starting HU at less than five years of age between January 1, 2008, and December 31, 2016.